Roivant Sciences (ROIV) Current Leases (2021 - 2026)

Roivant Sciences has reported Current Leases for 6 years, with the latest figure at $11.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 13.26% year-over-year to $11.1 million; the trailing twelve-month figure through Mar 2026 stood at $11.1 million (up 13.26% YoY), and the FY2026 full-year result was $11.1 million, up 13.26% from the prior year.
• Current Leases for Q1 2026 stood at $11.1 million, up from $10.4 million in the prior quarter.
• The five-year high for Current Leases was $11.9 million in Q4 2022, with the low at $9.0 million in Q1 2024.
• Historically, Current Leases has averaged $10.5 million across 5 years, with a median of $10.5 million in 2023.
• Annual changes were most pronounced in 2024 — Current Leases declined 23.32% — and 2026, when it gained 13.26%.
• Roivant Sciences' Current Leases stood at $11.9 million in 2022, then retreated by 11.68% to $10.5 million in 2023, then declined by 6.13% to $9.8 million in 2024, then rose by 6.11% to $10.4 million in 2025, then climbed by 6.81% to $11.1 million in 2026.
• The last three Current Leases figures came in at $11.1 million (Q1 2026), $10.4 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.